{"title":"From brain to heart: Causality and therapeutic potential in atrial fibrillation","authors":"Kaiyuan Li, Zongyi Xia, Chi Zhou, Zhexun Lian","doi":"10.1016/j.jstrokecerebrovasdis.2025.108394","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To elucidate the causal relationship between resting-state brain function and atrial fibrillation (AF), and to pinpoint potential genetic targets and therapeutic compounds for AF.</div></div><div><h3>Methods</h3><div>Employing GTEx V8 eQTL and deCODE Genetics pQTL datasets, key genes associated with AF were identified through Mendelian Randomization (MR) and Summary-based Mendelian Randomization (SMR) analyses. Colocalization analysis was subsequently conducted to confirm the shared genetic loci influencing both brain function and AF. In addition, transcriptome differential expression and pathway enrichment analysis were undertaken to delineate the potential molecular mechanism. Drug screening and molecular docking are employed to evaluate the therapeutic efficacy of the candidate compounds.</div></div><div><h3>Results</h3><div>MR Analysis revealed a significant causal relationship between resting-state brain functions of the default mode network (DMN) and central executive network (CEN) and AF. SMR and co-localization analyses identify the WIPF1 gene as a key genetic locus shared with brain function and AF. Candidate compounds C<sub>12</sub>H<sub>12</sub>N<sub>4</sub>S, C<sub>16</sub>H<sub>15</sub>N<sub>5</sub>O<sub>2</sub> and C<sub>16</sub>H<sub>13</sub>NO<sub>6</sub> showed anti-inflammatory and antibacterial properties, and exhibited good binding affinity in molecular docking, supporting their potential as therapeutic agents.</div></div><div><h3>Conclusions</h3><div>This study reveals a novel genetic association between resting-state brain function and AF and identifies WIPF1 as a potential therapeutic target, offering fresh insights into the study of brain-heart interaction and targeted treatment strategies for AF.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 9","pages":"Article 108394"},"PeriodicalIF":2.0000,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Stroke & Cerebrovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1052305725001727","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To elucidate the causal relationship between resting-state brain function and atrial fibrillation (AF), and to pinpoint potential genetic targets and therapeutic compounds for AF.
Methods
Employing GTEx V8 eQTL and deCODE Genetics pQTL datasets, key genes associated with AF were identified through Mendelian Randomization (MR) and Summary-based Mendelian Randomization (SMR) analyses. Colocalization analysis was subsequently conducted to confirm the shared genetic loci influencing both brain function and AF. In addition, transcriptome differential expression and pathway enrichment analysis were undertaken to delineate the potential molecular mechanism. Drug screening and molecular docking are employed to evaluate the therapeutic efficacy of the candidate compounds.
Results
MR Analysis revealed a significant causal relationship between resting-state brain functions of the default mode network (DMN) and central executive network (CEN) and AF. SMR and co-localization analyses identify the WIPF1 gene as a key genetic locus shared with brain function and AF. Candidate compounds C12H12N4S, C16H15N5O2 and C16H13NO6 showed anti-inflammatory and antibacterial properties, and exhibited good binding affinity in molecular docking, supporting their potential as therapeutic agents.
Conclusions
This study reveals a novel genetic association between resting-state brain function and AF and identifies WIPF1 as a potential therapeutic target, offering fresh insights into the study of brain-heart interaction and targeted treatment strategies for AF.
期刊介绍:
The Journal of Stroke & Cerebrovascular Diseases publishes original papers on basic and clinical science related to the fields of stroke and cerebrovascular diseases. The Journal also features review articles, controversies, methods and technical notes, selected case reports and other original articles of special nature. Its editorial mission is to focus on prevention and repair of cerebrovascular disease. Clinical papers emphasize medical and surgical aspects of stroke, clinical trials and design, epidemiology, stroke care delivery systems and outcomes, imaging sciences and rehabilitation of stroke. The Journal will be of special interest to specialists involved in caring for patients with cerebrovascular disease, including neurologists, neurosurgeons and cardiologists.